In an international, randomized trial of 1,554 patients with septic shock who had already received > 1 liter of intravenous fluids, patients assigned to the restrictive-fluid group compared to the standard-fluid group did not have reduced mortality at 90 days.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.